To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus

NCT00550095 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
509
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis